HANISH ARNOLD C

SEC source: 0001233253-26-000006 · ownership.xml · nonDerivative · entry 1

HANISH ARNOLD C · CIK 0001233253 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 3,418

F1 · kind: Restricted stock granted under the Decoy Therapeutics Inc. 2026 Equity Incentive Plan, 100 percent will vest on August 30, 2027.

F2 · balance_after: Shares beneficially owned following the transaction have been adjusted to reflect the reverse stock split effective on March 6, 2026.

SEC source: 0001437749-26-029191 · rdgdoc.xml · derivative · entry 10

HANISH ARNOLD C · CIK 0001233253 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 0

Underlying: Common Stock · 7,500 shares

Expires 2030-06-04

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

SEC source: 0001437749-26-029191 · rdgdoc.xml · derivative · entry 9

HANISH ARNOLD C · CIK 0001233253 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 0

Underlying: Common Stock · 2,500 shares

Expires 2031-06-10

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

SEC source: 0001437749-26-029191 · rdgdoc.xml · nonDerivative · entry 6

HANISH ARNOLD C · CIK 0001233253 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 0

F3 · price: This transaction was executed in multiple trades at prices ranging from $19.00 to $19.10. The price reported above reflects the weighted average sales price. The reporting person hereby undertakes to provide full information regarding the number of shares and prices at which the transactions referenced in this footnote were effected upon request to the SEC staff, the issuer, or a security holder of the issuer.

SEC source: 0001437749-26-029191 · rdgdoc.xml · nonDerivative · entry 5

HANISH ARNOLD C · CIK 0001233253 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 5,000

F2 · price: This transaction was executed in multiple trades at prices ranging from $18.85 to $18.92. The price reported above reflects the weighted average sales price. The reporting person hereby undertakes to provide full information regarding the number of shares and prices at which the transactions referenced in this footnote were effected upon request to the SEC staff, the issuer, or a security holder of the issuer.

SEC source: 0001437749-26-029191 · rdgdoc.xml · nonDerivative · entry 4

HANISH ARNOLD C · CIK 0001233253 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 10,000

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

SEC source: 0001437749-26-029191 · rdgdoc.xml · nonDerivative · entry 3

HANISH ARNOLD C · CIK 0001233253 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 2,500

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

SEC source: 0001437749-26-029191 · rdgdoc.xml · derivative · entry 8

HANISH ARNOLD C · CIK 0001233253 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 2,500

Underlying: Common Stock · 5,000 shares

Expires 2031-06-10

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

SEC source: 0001437749-26-029191 · rdgdoc.xml · nonDerivative · entry 2

HANISH ARNOLD C · CIK 0001233253 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 0

F1 · price: This transaction was executed in multiple trades at prices ranging from $18.50 to $18.56. The price reported above reflects the weighted average sales price. The reporting person hereby undertakes to provide full information regarding the number of shares and prices at which the transactions referenced in this footnote were effected upon request to the SEC staff, the issuer, or a security holder of the issuer.

SEC source: 0001437749-26-029191 · rdgdoc.xml · nonDerivative · entry 1

HANISH ARNOLD C · CIK 0001233253 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 5,000

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

SEC source: 0001437749-26-021237 · rdgdoc.xml · derivative · entry 1

HANISH ARNOLD C · CIK 0001233253 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 15,000

Underlying: Common Stock · 15,000 shares

Expires 2036-06-17

F1 · security: Pursuant to Omeros Corporation's non-employee director compensation policy, on the date of each annual meeting of shareholders, each non-employee director who has served as a director for at least six months and who will continue to serve as a director after the annual meeting is automatically granted an option to purchase 15,000 shares of common stock. This Form 4 reports the annual stock option award granted to the reporting person in conjunction with the annual meeting of shareholders held on June 18, 2026.

F2 · derivative.exercise_date: This option will fully vest and become exercisable on the day before the date of the 2027 annual meeting of the shareholders of Omeros Corporation, provided that the reporting person continues to serve as a director of the company through such date.

SEC source: 0001615219-26-000004 · wk-form4_1767392031.xml · nonDerivative · entry 2

HANISH ARNOLD C · CIK 0001233253 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 0

SEC source: 0001615219-26-000004 · wk-form4_1767392031.xml · nonDerivative · entry 1

HANISH ARNOLD C · CIK 0001233253 · Director

10b5-1 filing: No plan indicated

Ownership: Indirect · By Arnold C. Hanish Trust

Disclosed balance after: 5,000

SEC source: 0001615219-25-000193 · wk-form4_1764022090.xml · nonDerivative · entry 1

HANISH ARNOLD C · CIK 0001233253 · Director

10b5-1 filing: No plan indicated

Ownership: Indirect · By Arnold C. Hanish Trust

Disclosed balance after: 5,015

F1 · price: The price reported in Column 4 is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $0.7437 to $0.75, inclusive. The reporting person undertakes to provide to Salarius Pharmaceuticals, Inc., any security holder of Salarius Pharmaceuticals, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the ranges set forth in footnote (1) to this Form 4.

SEC source: 0001437749-25-021792 · rdgdoc.xml · derivative · entry 1

HANISH ARNOLD C · CIK 0001233253 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 15,000

Underlying: Common Stock · 15,000 shares

Expires 2035-06-27

F1 · security: Pursuant to Omeros Corporation's non-employee director compensation policy, on the date of each annual meeting of shareholders, each non-employee director who has served as a director for at least six months and who will continue to serve as a director after the annual meeting is automatically granted an option to purchase 15,000 shares of common stock. This Form 4 reports the annual stock option award granted to the reporting person in conjunction with the annual meeting of shareholders held on June 27, 2025.

F2 · derivative.exercise_date: This option will fully vest and become exercisable on the day before the date of the 2026 annual meeting of the shareholders of Omeros Corporation, provided that the reporting person continues to serve as a director of the company through such date.

SEC source: 0001437749-24-019707 · rdgdoc.xml · derivative · entry 1

HANISH ARNOLD C · CIK 0001233253 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 15,000

Underlying: Common Stock · 15,000 shares

Expires 2034-06-06

F1 · security: Pursuant to Omeros Corporation's non-employee director compensation policy, on the date of each annual meeting of shareholders, each non-employee director who has served as a director for at least six months and who will continue to serve as a director after the annual meeting is automatically granted an option to purchase 15,000 shares of common stock. This Form 4 reports the annual stock option award granted to the reporting person in conjunction with the annual meeting of shareholders held on June 6, 2024.

F2 · derivative.exercise_date: This option will fully vest and become exercisable on the day before the date of the 2025 annual meeting of the shareholders of Omeros Corporation, provided that the reporting person continues to serve as a director of the company through such date.

SEC source: 0001615219-24-000003 · wk-form4_1708636159.xml · derivative · entry 1

HANISH ARNOLD C · CIK 0001233253 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 20,500

Underlying: Common Stock · 20,500 shares

Expires 2034-02-19

SEC source: 0001415889-23-010376 · form4-06272023_110620.xml · derivative · entry 1

HANISH ARNOLD C · CIK 0001233253 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 15,000

Underlying: Common Stock · 15,000 shares

Expires 2033-06-23

F1 · security: Pursuant to Omeros Corporation's non-employee director compensation policy, on the date of each annual meeting of shareholders, each non-employee director who has served as a director for at least six months and who will continue to serve as a director after the annual meeting is automatically granted an option to purchase 15,000 shares of common stock. This Form 4 reports the annual stock option award granted to the reporting person in conjunction with the annual meeting of shareholders held on June 23, 2023.

F2 · derivative.exercise_date: This option will fully vest and become exercisable on the day before the date of the 2024 annual meeting of the shareholders of Omeros Corporation, provided that the reporting person continues to serve as a director of the company through such date.

SEC source: 0001415889-23-008651 · form4-05232023_090541.xml · derivative · entry 4

HANISH ARNOLD C · CIK 0001233253 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 0

Underlying: Common Stock · 5,000 shares

Expires 2023-05-23

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

SEC source: 0001415889-23-008651 · form4-05232023_090541.xml · nonDerivative · entry 2

HANISH ARNOLD C · CIK 0001233253 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 0

F1 · price: This transaction was executed in multiple trades at prices ranging from $6.34 to $6.61. The price reported above reflects the weighted average sales price. The reporting person hereby undertakes to provide full information regarding the number of shares and prices at which the transactions referenced in this footnote were effected upon request to the SEC staff, the issuer, or a security holder of the issuer.

SEC source: 0001415889-23-008651 · form4-05232023_090541.xml · nonDerivative · entry 1

HANISH ARNOLD C · CIK 0001233253 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 5,000

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

SEC source: 0001615219-23-000011 · wf-form4_167295996189260.xml · nonDerivative · entry 1

HANISH ARNOLD C · CIK 0001233253 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 1,440

F1 · kind: Restricted stock granted under the Salarius Pharmaceuticals, Inc.2015 Equity Incentive Plan. 100% of the restricted stock will vest on January 2, 2024

SEC source: 0001415889-22-009929 · form4-09232022_050922.xml · derivative · entry 1

HANISH ARNOLD C · CIK 0001233253 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 7,500

Underlying: Common Stock · 7,500 shares

Expires 2032-09-21

F1 · derivative.exercise_date: This option will fully vest and become exercisable on the day before the date of the 2023 annual meeting of the shareholders of Omeros Corporation, provided that the participant continues to serve as a director of the company through such date.

SEC source: 0001415889-22-006849 · form4-06222022_020623.xml · derivative · entry 1

HANISH ARNOLD C · CIK 0001233253 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 7,500

Underlying: Common Stock · 7,500 shares

Expires 2032-06-17

F1 · security: Pursuant to Omeros Corporation's non-employee director compensation policy, on the date of each annual meeting of shareholders, each non-employee director who has served as a director for at least six months and who will continue to serve as a director after the annual meeting is automatically granted an option to purchase 7,500 shares of common stock. This Form 4 reports the annual stock option award granted to the reporting person in conjunction with the annual meeting of shareholders held on June 17, 2022.

F2 · derivative.exercise_date: This option will fully vest and become exercisable on the day before the date of the 2023 annual meeting of the shareholders of Omeros Corporation, provided that the participant continues to serve as a director of the company through such date.

SEC source: 0001615219-22-000095 · wf-form4_165456196752108.xml · nonDerivative · entry 1

HANISH ARNOLD C · CIK 0001233253 · Director

10b5-1 filing: Not disclosed

Ownership: Indirect · By Arnold C. Hanish Trust

Disclosed balance after: 46,350

SEC source: 0001615219-22-000006 · wf-form4_164279914764399.xml · derivative · entry 1

HANISH ARNOLD C · CIK 0001233253 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 30,000

Underlying: Common Stock · 30,000 shares

Expires 2032-01-19

SEC source: 0001415889-21-004308 · form4-09092021_020920.xml · derivative · entry 2

HANISH ARNOLD C · CIK 0001233253 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 5,000

Underlying: Common Stock · 10,000 shares

Expires 2022-09-25

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · shares: On September 8, 2021, 2021, the reporting person paid the exercise price and exercised options to purchase a total of 10,000 shares of the company's common stock. These shares have not been sold and are held of record by the Arnold C. Hanish Living Trust, for which the reporting person serves as sole trustee.

SEC source: 0001415889-21-004308 · form4-09092021_020920.xml · nonDerivative · entry 1

HANISH ARNOLD C · CIK 0001233253 · Director

10b5-1 filing: Not disclosed

Ownership: Indirect · See footnote

Disclosed balance after: 10,000

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · ownership.nature: On September 8, 2021, 2021, the reporting person paid the exercise price and exercised options to purchase a total of 10,000 shares of the company's common stock. These shares have not been sold and are held of record by the Arnold C. Hanish Living Trust, for which the reporting person serves as sole trustee.

SEC source: 0001615219-21-000085 · wf-form4_162871242411942.xml · nonDerivative · entry 1

HANISH ARNOLD C · CIK 0001233253 · Director

10b5-1 filing: Not disclosed

Ownership: Indirect · By Arnold C. Hanish Trust

Disclosed balance after: 18,350

SEC source: 0001415889-22-001320 · form4-02142022_020204.xml · derivative · entry 1

HANISH ARNOLD C · CIK 0001233253 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 7,500

Underlying: Common Stock · 7,500 shares

Expires 2031-06-10

F1 · security: Pursuant to Omeros Corporation's non-employee director compensation policy, on the date of each annual meeting of shareholders, each non-employee director who has served as a director for at least six months and who will continue to serve as a director after the annual meeting is automatically granted an option to purchase 7,500 shares of common stock. This Form 4 reports the annual stock option award granted to the reporting person in conjunction with the annual meeting of shareholders held on June 11, 2021.

F2 · derivative.exercise_date: This option will fully vest and become exercisable on the day before the date of the 2022 annual meeting of the shareholders of Omeros Corporation, provided that the participant continues to serve as a director of the company through such date.

SEC source: 0001615219-20-000119 · wf-form4_160711921909433.xml · derivative · entry 1

HANISH ARNOLD C · CIK 0001233253 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 30,000

Underlying: Common Stock · 30,000 shares

Expires 2030-12-01

SEC source: 0001615219-20-000099 · wf-form4_159827081943052.xml · nonDerivative · entry 1

HANISH ARNOLD C · CIK 0001233253 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 11,350

SEC source: 0001615219-22-000093 · wf-form4a_165456185934953.xml · nonDerivative · entry 1

HANISH ARNOLD C · CIK 0001233253 · Director

10b5-1 filing: Not disclosed

Ownership: Indirect · By Arnold C. Hanish Trust

Disclosed balance after: 11,350

F1 · security: This Form 4/A is being filed to amend the Form 4 filed by the Reporting Person on August 24, 2020 to reflect that the securities reported are indirectly beneficially owned as indicated herein.

SEC source: 0001415889-20-001531 · form4-06092020_070601.xml · derivative · entry 1

HANISH ARNOLD C · CIK 0001233253 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 7,500

Underlying: Common Stock · 7,500 shares

Expires 2030-06-04

F1 · derivative.exercise_date: This option will fully vest and become exercisable on the day before the date of the 2021 annual meeting of the shareholders of Omeros Corporation, provided that the participant continues to serve as a director of the company through such date.

SEC source: 0001615219-20-000026 · wf-form4_158517374401896.xml · derivative · entry 1

HANISH ARNOLD C · CIK 0001233253 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 6,000

Underlying: Common Stock · 6,000 shares

Expires 2030-03-22

F1 · derivative.exercise_date: Options granted are fully vested on March 23, 2021.

SEC source: 0000899243-20-004418 · doc4.xml · nonDerivative · entry 1

HANISH ARNOLD C · CIK 0001233253 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 7,350

SEC source: 0000899243-20-004560 · doc4.xml · derivative · entry 1

HANISH ARNOLD C · CIK 0001233253 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 4,350

Underlying: Common Stock · 4,350 shares

Expires 2025-02-11

F1 · security: The Reporting Person acquired these securities in the Issuer's public offering of Class A Units on February 11, 2020. Each Class A Unit consisted of one share of Common Stock and one warrant to purchase a single share of Common Stock.

SEC source: 0001615219-22-000091 · wf-form4a_165456170682482.xml · nonDerivative · entry 1

HANISH ARNOLD C · CIK 0001233253 · Director

10b5-1 filing: Not disclosed

Ownership: Indirect · By Arnold C. Hanish Trust

Disclosed balance after: 7,350

F1 · security: This Form 4/A is being filed to amend the Form 4 filed by the Reporting Person on February 12, 2020 to reflect that the securities reported are indirectly beneficially owned as indicated herein.

SEC source: 0001615219-19-000055 · wf-form4_157477604835031.xml · nonDerivative · entry 1

HANISH ARNOLD C · CIK 0001233253 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 6,000

SEC source: 0000899243-20-004410 · doc4a.xml · nonDerivative · entry 1

HANISH ARNOLD C · CIK 0001233253 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 3,000

F1 · security: This Form 4/A is being filed to amend the Form 4 filed by the Reporting Person on November 26, 2019 to correct the amount of securities beneficially owned following the reported transaction under Box 5 of Table I as reflected herein.

SEC source: 0001615219-22-000089 · wf-form4a_165456160903374.xml · nonDerivative · entry 1

HANISH ARNOLD C · CIK 0001233253 · Director

10b5-1 filing: Not disclosed

Ownership: Indirect · By Arnold C. Hanish Trust

Disclosed balance after: 3,000

F1 · security: This Form 4/A is being filed to amend the Form 4 filed by the Reporting Person on November 26, 2019 to reflect that the securities reported are indirectly beneficially owned as indicated herein.

SEC source: 0001615219-19-000030 · wf-form4_156833986050609.xml · derivative · entry 1

HANISH ARNOLD C · CIK 0001233253 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 3,000

Underlying: Common Stock · 3,000 shares

Expires 2029-09-10

SEC source: 0000899243-19-016495 · doc4.xml · derivative · entry 1

HANISH ARNOLD C · CIK 0001233253 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 7,500

Underlying: Common Stock · 7,500 shares

Expires 2029-06-06

F1 · derivative.exercise_date: This option will fully vest and become exercisable on the day before the date of the 2020 annual meeting of the shareholders of Omeros Corporation, provided that the participant continues to serve as a director of the company through such date.

SEC source: 0000899243-18-017011 · doc4.xml · derivative · entry 1

HANISH ARNOLD C · CIK 0001233253 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 7,500

Underlying: Common Stock · 7,500 shares

Expires 2028-06-14

F1 · derivative.exercise_date: This option will fully vest and become exercisable on the day before the date of the 2019 annual meeting of the shareholders of Omeros Corporation, provided that the participant continues to serve as a director of the company through such date.

SEC source: 0000899243-17-016619 · doc4.xml · derivative · entry 1

HANISH ARNOLD C · CIK 0001233253 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 10,000

Underlying: Common Stock · 10,000 shares

Expires 2027-06-15

F1 · derivative.exercise_date: This option will fully vest and become exercisable on the day before the date of the 2018 annual meeting of the shareholders of Omeros Corporation, provided that the participant continues to serve as a director of the company through such date.

SEC source: 0001209191-12-050900 · doc4.xml · nonDerivative · entry 1

HANISH ARNOLD C · CIK 0001233253 · Chief Accounting Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 17,611

SEC source: 0001209191-12-029433 · doc4.xml · nonDerivative · entry 2

HANISH ARNOLD C · CIK 0001233253 · Chief Accounting Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 17,747

SEC source: 0001209191-12-029433 · doc4.xml · nonDerivative · entry 1

HANISH ARNOLD C · CIK 0001233253 · Chief Accounting Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 19,042

SEC source: 0001209191-12-006102 · doc4.xml · nonDerivative · entry 1

HANISH ARNOLD C · CIK 0001233253 · Chief Accounting Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 19,255

SEC source: 0001209191-12-007171 · doc4a.xml · nonDerivative · entry 1

HANISH ARNOLD C · CIK 0001233253 · Chief Accounting Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 19,280

F1 · shares: This amendment is being filed to correct the number of securities reported as acquired on the original Form 4 filed on 1/30/2012; 25 shares were inadvertently omitted from the total.